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Available online 9 December 2012Abstract Human embryonic stem cells (hESCs) can be used to model the cellular and molecular mechanisms that underlie
embryonic development. Understanding the cellular mechanisms and pathways involved in extraembryonic (ExE)
differentiation is of great interest because of the important role of this process in maternal health and fertility. Fibroblast
growth factor 2 (FGF-2) is widely used to maintain the self-renewal of hESCs and induced pluripotent stem cells, while all trans
retinoic acid (RA) is used to facilitate the directed differentiation of hESCs. Here, we monitored the RA induced differentiation
of hESCs to the ExE lineage with and without FGF-2 over a 7-day period via global transcriptional profiling. The stemness
markers POU5F1, NANOG and TDGF1 were markedly downregulated, whereas an upregulation of the ExE markers KRT7, CGA,
DDAH2 and IGFBP3 was observed. Many of the differentially expressed genes were involved in WNT and TGF-β signaling. RA
inactivated WNT signaling even in the presence of exogenous FGF-2, which that promotes the maintenance of the pluripotent
state. We also show that BMP4 was upregulated and that RA was able to modulate the TGF-β signaling pathway and direct hESCs
toward the ExE lineage. In addition, an epigenetic study revealed hypermethylation of the DDAH2, TDGF1 and GATA3 gene
promoters, suggesting a role for epigenetic regulation during ExE differentiation. These data reveals that the effect of RA
prevails in the presence of exogenous FGF-2 thus resulting in the direction of hESCs toward the ExE lineage.
© 2012 Elsevier B.V. All rights reserved.IntroductionHuman embryonic stem cells (hESCs) derived from the inner
cell mass of blastocysts are pluripotent and self-renewing
cells that are capable of differentiating into all organ-Abbreviations: hESCs, human embryonic stem cells; RA, all-trans
retinoic acid; ExE, extraembryonic; FGF-2, basic fibroblast growth
factor; MEF, mouse embryonic fibroblasts; TGF-β, transforming
growth factor beta.
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http://dx.doi.org/10.1016/j.scr.2012.12.002specific cell types (Greber et al., 2007). hESCs were initially
grown in serum-containing medium on feeder layers of
inactivated mouse embryonic fibroblasts (MEFs), thus,
allowing them to maintain their ability to self-renewing or
to differentiate depending on the cell culture conditions
(Thomson et al., 1998). Defined media such as StemPro and
mTeSR are often used to culture hESCs in the absence of the
supportive feeder cells (Ludwig et al., 2006). Growth factor
supplements commonly used to promote self-renewal in
hESC cultures include fibroblast growth factor-2 (FGF-2)
229All-trans retinoic acid induces extraembryonic differentiation(Dvorak et al., 2005; Levenstein et al., 2006), transforming
growth factor beta1 (TGF-β1) (Amit et al., 2004), activin A
(Vallier et al., 2005), and Wnt1 (Cai et al., 2007; Dravid et
al., 2005). FGFs are secreted polypeptide ligands that are
essential for the initiation, growth and maturation of many
tissues and organs during embryonic, fetal and postnatal
vertebrate development (Goldfarb, 1996). The external
addition of FGF-2 activates FGF receptors and their down-
stream targets, such as mitogen-activated protein kinase
(MAPK) and participates in maintaining the undifferentiated
growth of hESCs by increasing self-renewal, cell survival and
adhesion (Eiselleova et al., 2009). In addition, FGF-2 has been
found in the embryonic ectoderm, muscle cells and limbs
from the initiation of budding through differentiation (Dono
et al., 1998; Savage et al., 1993; Storey et al., 1998). Fur-
thermore, bone morphogenetic protein (BMP) signaling
sustains the differentiation of hESCs into various lineages,
including the extraembryonic (ExE) lineage (Pera et al., 2004;
Xu et al., 2002). A combination of FGF, activin/nodal and BMP
signaling coordinates the early lineage segregation of hESCs
(Erlebacher et al., 2004; Wu et al., 2008). BMPs belong to the
TGF-β superfamily which includes activins and inhibins.
TGF-β signaling has a vital role in stem cell development,
organogenesis (Kitisin et al., 2007) and the maintenance of
pluripotency (James et al., 2005). The synergism of BMP-4
and FGF-2 signaling is imperative to direct trophoblast
differentiation (Das et al., 2007; Golos et al., 2006; Xu et
al., 2002).
All-trans retinoic acid (RA) belongs to the retinoid family,
a group of analogs of vitamin A (retinols), and regulates
embryonic growth and patterning decisions. RA acts as a
ligand for inactive transcription factors and enables them to
bind to nuclear retinoic acid receptor (RAR), thus switching
the transcription factors to transcriptional activators (for
review see (Rhinn and Dolle, 2012). RA, which is used for the
treatment of cystic acne and other chronic skin disorders, is
considered to be teratogenic in humans when taken during
early pregnancy (Klug et al., 1989), to be embryotoxic
following exposure prior to and during early organogenesis in
the cynomolgus monkey (Hendrickx and Hummler, 1992) and
to cause limb deformities in mice (Collins et al., 2006). RA is
a critical signaling molecule during embryogenesis and is
responsible for proximodistal patterning, limb development
and regeneration, neural differentiation and axon outgrowth
(Maden, 2007; Yashiro et al., 2004). A deficiency of RA
during development results in a spectrum of malformations
that includes defects of the lungs, cardiovascular system and
urogenital system (MorrissKay and Sokolova, 1996). RA is
regularly used to direct the in vitro differentiation of ESCs
toward the pancreatic cell fate, epithelial, neural and
smooth muscle cell fates (Dhara and Stice, 2008; Metallo et
al., 2008; Potta et al., 2009; Shim et al., 2007).
Previously, RA and FGF-2 have been used together to
induce neuronal differentiation. FGF-2 has been introduced
not only during the early stages of neurogenesis but also to
regulate processes that occur in the later stages, such as
the caudalization of neuronal tissues, motor neuron speci-
fication and the enhancement of the proliferation of
neuronal progenitor cells (Baharvand et al., 2007). The
external addition of RA to trophoblast stem cells augments
the formation of giant cells and causes a reduction in
spongiotrophoblasts via the expression of RARβ in trophoblastcell fate specification during placentation (Yan et al., 2001).
Homogeneous expression of FGF and its receptors was
observed in bovine trophoblast giant cells, and the external
addition of growth factors in the presence of extra cellular
matrix on blastocysts synergistically promotes trophoblast
outgrowth and could influence implantation (Haimovici and
Anderson, 1993; Pfarrer et al., 2006). The ExE lineage which is
essential for the survival of the embryo in the uterine
environment arises from trophectoderm and primitive endo-
derm. These two types of cell lineage largely contribute to the
ExE membranes, such as the placenta and the yolk sac. A
number of signaling pathways and transcription factors are
implicated in the perpetuation of these lineages (Rossant,
1995). During pre-implantation and conceptus development,
bovine trophoblast cell migration, reorganization and mor-
phogenesis are influenced by the FGF-2 and FGF-10. The
interaction between FGF and RA has been successfully utilized
previously for anterior–posterior neural patterning, endo-
derm patterning and the initiation of differentiation in
vertebrate body axis formation in extending limbs using
different in vitro methods (Johannesson et al., 2009;
Olivera-Martinez and Storey, 2007; Shiotsugu et al., 2004).
We hypothesized that the synergistic effect of two mutually
opposing morphogens in early embryonic development in
hESCs may at least partially elucidate the mechanism of ExE
lineage development. To elucidate the combinatorial effect of
RA and FGF-2 on the lineage decisions of hESCs and to identify
mechanisms by which RA might bypass the self-renewal
signaling pathway induced by FGF-2 in hESCs to thereby
promote ExE lineage differentiation, we investigated the
effect of RA in the presence and absence of FGF-2 using global
expression microarrays.Methods
Media and cell culture
H9 hESCs (WiCell, Madison, WI, USA) at passages 38 to 45 were
expanded on irradiated MEFs in knockout (KO)-DMEM-F12, 20%
KO serum replacement, 1% non-essential amino acids, peni-
cillin (100 units/ml)/streptomycin (100 mg/ml) and 0.1 mM
β-mercaptoethanol supplemented with 4 ng/ml FGF-2. For
experiments, cells were cultured on plates coated with
Matrigel (BD Scientific) in conditioned medium (CM). CM was
prepared by conditioning unconditioned medium on fibroblast
(CF1 feeders) overnight and then supplementing with FGF-2
(final concentration 8 ng/ml). RA treatment was performed
at a 5 μM concentration, which is not cytotoxic to ESCs
(Zhuang and Gudas, 2008). For treatments, RA was added on
day 0 in the presence or absence of FGF-2 in the medium, and
the vehicle was added to the controls. Experiments were
performed with three biological replicates. Cells were
harvested on day 7, lysed in TRIzol and processed for RNA
isolation (see below).
Cell proliferation assay
The cell proliferation assay was performed as previously
described (Jagtap et al., 2011). Briefly, hESC colonies were
dissociated with StemPro Accutase (Invitrogen, Carlsbad,
230 S. Jagtap et al.CA) and 25,000 cells were seeded with mTeSR (Stemcell
Technologies, Grenoble, France) medium in 96-well flat-
bottom cell culture plates coated with hESC-qualified matrix
(BD Biosciences, California, USA). Two days later, the
medium was removed completely and replenished with RA
(0.3 to 1000 μM)-containing medium. On the third day, the
medium was removed completely, and 20 ml of CellTiter
96® AQueous MTS and phenazine methosulphate (Sigma,
Steinheim, Germany) solution with 100 μl of mTeSR was
added according to the manufacturer's instructions. After
1–2 h incubation at 37 °C, the absorbance was measured
with a TECAN spectrophotometer at 490 nm. Three inde-
pendent experiments were performed for this study. The
inhibitory concentration values were calculated with GraphPad
Prism 4 software.
Microarray hybridization, data analysis and
statistical procedures
Total RNA was extracted using TRIzol and the RNeasy mini kit
(Qiagen) according to the manufacturer's instructions. For
microarray analysis, 100 ng of total RNA was amplified using
the Genechip 3′ IVT Express Kit (Affymetrix) according to the
manufacturer's instructions. Amplified RNA (aRNA) purifica-
tion was performed using magnetic beads, and 15 μg of aRNA
was fragmented according to the manufacturer's guidelines.
Next, 12.5 μg of fragmented aRNA was hybridized to
human genome HG-U133 plus2.0 arrays in the Genechip
Hybridization Oven-645 (Affymetrix). The Affymetrix HWS
kit was used for staining and washing using the Genechip
Fluidics Station-450. The stained arrays were scanned
with Affymetrix Gene-Chip Scanner-3000-7G, and a quality
control analysis was performed by Affymetrix GCOS soft-
ware. All microarray data analyses and visualization were
performed using the Partek Genomics Suite version 6.6.
Intensity values were generated by RMA background correc-
tion, quantile normalization log2 transformation and median
polished probe set summarization. To examine the gene
expression changes of 54,675 normalized probes, a principal
component (PC) analysis was performed using the Partek
genomic suite version 6.6. One-way ANOVA was used to
identify differentially expressed genes (+RA+FGF-2 vs.
−RA−FGF-2) that exhibited at least a 2-fold change with
FDR correction Pb0.05. Heatmap expression values were
normalized by standardizing shift genes to a mean of zero
and scaling to a standard deviation of one. Gene ontolo-
gy (GO) terms were investigated for the differentially
expressed genes using the Database for Annotation, Visual-
ization and Integrated Discovery (DAVID) (Dennis et al.,
2003).
Real-time quantitative polymerase chain reactions,
western blotting, immunocytochemistry and
enzyme-linked immunosorbent assay
Total RNA was extracted as described above. RNA was
reverse-transcribed using Super Script Vilo (Invitrogen,
Carlsbad, CA) using 2 μg of total RNA. cDNA was diluted
20-fold with nuclease-free water, and 100 ng was used as a
template for PCR. Quantitative real-time polymerase chain
reactions (qRT-PCR) were carried out on Applied Biosystems7500 FAST cycler, and the primer sequences are provided in
Supplementary Table 1. Relative mRNA levels were calculated
using the ΔΔCt method and represented relative to house-
keeping gene expression.
Western blotting was performed for 30 μg of protein
from RA-treated and -untreated samples separated by SDS-
polyacrylamide gel electrophoresis and blotted onto nitro-
cellulose membranes. Membranes were blocked with 5%
bovine serum albumin (BSA) at room temperature and then
incubated overnight at 4 °C on orbital shakers with the
following primary antibodies in 1% BSA: phospho SMAD1/5
(Millipore), total SMAD1/5 (millipore), KRT7 (Cell Signaling
Technology, Frankfurt, Germany), MUC15 (Abcam, Cambridge,
UK), GATA3 (Cell Signaling Technology, Frankfurt, Germany),
GATA6 (Abgent, Europe, UK), TFAP2α (Cell Signaling Technol-
ogy, Frankfurt, Germany) and β-ACTIN (Sigma, Steinheim,
Germany). After washing with PBST (PBS with 0.1%
Tween-20), membranes were incubated with the appropri-
ate secondary antibody for each primary antibody and
labeled with HRP for 1 h at room temperature. The
antibodies were detected using the ECL (Fisher Scientific
GmbH, Schwerte, Germany) Western detection system. For
immunostaining, hESC cultures were grown on fibronectin-
coated glass slips in the presence and absence of FGF-2
and RA, fixed with 4% paraformaldehyde for 15 min and
on day 5 were permeabilized with PBS-Triton X-100.
Samples were blocked with 5% BSA for 1 h and incubated
overnight at 4 °C with the following primary antibodies: β-
catenin (BD sciences, Heidelberg, Germany), KRT7, TFAP2α
and GATA3 (Cell Signaling, Frankfurt, Germany)). After
washing, samples were treated with a PE-conjugated, species-
specific secondary antibody for 1 h at 4 °C. 4′-6-Diamidino-
2-phenylindole was used to detect nuclei. The samples were
mounted in Prolong gold (Invitrogen, Darmstadt, Germany)
and observed under a Zeiss Axiovert 200 fluorescence micro-
scope (Carl Zeiss Microscopy, Oberkochen, Germany). Enzyme
linked immunosorbent assays (ELISAs) were carried out for
hCG and samples were harvested from RA-treated hESC
cultures that were either co-treated or not treated with
FGF-2 by collecting medium from days 3–7 and were com-
pared to untreated samples using the ELISA kit ab100533
from Abcam, Cambridge, UK according to the manufacturer's
recommendations.Genomic DNA isolation and EpiTect methyl q-PCR
analysis
Genomic DNA was isolated using the DNeasy kit (Qiagen)
according to the manufacturer's instructions. Briefly, cell
pellets were digested with 20 μl proteinase K, and treated
with RNase A and processed further according to the
instructions. A total of 250 ng of genomic DNA per sample
was digested with the EpiTect Methyl DNA restriction kit
according to the provided instructions. qPCR assays were
performed with RT2 SYBR Green ROX master mix, and EpiTect
methyl qPCR assay primers (DDAH2, GATA3, TDGF1 and
EOMES) were used according to the provided instructions.
To calculate the percentages of unmethylated (UM), hyper-
methylated (HM) and intermediately methylated (IM) DNA,
cycle threshold (Ct) values were used according to the
manufacturer's instructions.
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Experimental design and cell morphology
Unconditioned medium (see Methods) was conditioned on
mouse embryonic fibroblasts (MEFs) overnight to obtain CM.
To assess the effect of RA on cell growth, MTS cell pro-
liferation assays were performed with various concentrations
of RA as mentioned in the Methods. At 5 μM, RA did not affect
the cell growth (Supplementary Fig. 1). We cultured hESCs on
Matrigel-coated plates in CM. To profile the effects of RA,
treatment of hESCs was performed at an RA concentration of
5 μM in the presence or absence of FGF-2 as shown in Fig. 1A.
Over a period of 7 days, most of the cells assumed a flattened
and enlarged morphology characteristic of primitive endo-
derm cells (Jetten et al., 1979). These changes were more
prominent in hESCs cultured in presence of both RA and+FGF-
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Figure 1 Treatment of undifferentiated hESCs with RA in the presen
The time points chosen for microarray analysis were on day 7. Th
expression of pluripotency markers. For each sample, gene expression
GAPDH gene expression (*P-value≤0.01).FGF-2, and RA-treated cells showed a compact morphology
(Fig. 1A). To examine the effects of RA with respect to FGF-2,
pluripotency markers were assessed by qRT-PCR. The expres-
sion levels of pluripotency markers such as, NANOG, POU5F1,
SOX2, FOXD3, TDGF1, LIN28 and PODXL were strongly de-
creased at day 7 of differentiation in hESC cultures in both
the presence and the absence of FGF-2 (Fig. 1B).Visualization of transcriptome alteration after RA
treatment of hESCs
Large-scale gene expression microarray studies were per-
formed to investigate global fundamental changes in gene
expression patterns during the treatment of hESCs with RA and
with respect to FGF-2. Principal component (PC) analysis
(PCA) of the transcripts resulted in two main characteristic
principal components, which represent 42.5% of the data set2 -FGF-2
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was normalized to controls (+FGF-2; −RA and −FGF-2; −RA) and
232 S. Jagtap et al.variance (Fig. 2A). The PCs are correlations between individ-
ual series and the associated PC score. The first and second
PCs account for 26.6% and 15.9% of the total variance,
respectively. The distance between the samples reflects the
degree of dissimilarity between them. As shown in Fig. 2A,
there was a clear separation between the transcriptomes
of the FGF-2-treated (+FGF-2−RA) and -untreated hESCs
(−FGF2−RA). Interestingly, the PC1 and PC2 distance of the
RA and FGF-2-treated hESCs (+FGF-2+RA) versus RA-treated
hESCs in the absence of FGF-2 (−FGF-2+RA) were very similar,
thus suggesting a similar transcriptomes independent of the150
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Figure 2 Whole-genome temporal gene expression profiling of RA
2443 transcripts that are dysregulated upon RA and FGF-2 treatmen
gene profile for pluripotency markers upon RA treatment.presence or absence of FGF-2. Fig. 2B summarizes a global
hierarchical cluster for 2443 differentially regulated tran-
scripts upon treatment of hESCs with RA. The number of genes
up and downregulated between the treatments increasedwith
RA, thus corroborating the fact that RA influences the
expression profile accordingly. We observed that genes that
control pluripotency were downregulated (Fig. 2C), while RA
receptors (RARA and RARB) were upregulated (Supplementary
Fig. 2). RA is primarily involved in patterning and neuronal
differentiation. The biological process analysis of differential-
ly expressed genes identified 102 genes that are involved in26 57 88 119 150
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233All-trans retinoic acid induces extraembryonic differentiationneuronal differentiation (Table 1). Among the 102 genes,
transcription factors such as OTX2, SOX1, LHX3, LHX8, PAX3,
SOX2 and SOX5 were downregulated. Furthermore,
microtubule-related genes such as MAP1B, MAP2, TUBB2A
and TUB2B were downregulated more than 2-fold with RA
treatment (+ or −FGF-2) treatment (Supplementary Fig. 3A).
By contrast, the early neuronal marker PAX6 and axon
guidance molecules such as SLITRK6, SLIT2, ROBO2 and
SEMA5A were upregulated more than 2-fold upon RA treat-
ment (Supplementary Fig. 3B).
Identification of signaling pathways possibly
implicated in extraembryonic differentiation
To identify biological processes and pathways deregulated
upon RA treatment in hESCs, we selected 2443 differentially
expressed genes (Supplementary Table 2). The gene ontology
(GO) categories and pathways that were overrepresented are
shown in Table 1 and the raw data for RA treatment with and
without FGF-2 are supplied in Supplementary Table 3. We
found that RA primarily dysregulated the WNT and TGF-β
signaling pathways. Our results identified 17 downregulated
and 12 upregulated genes involved in WNT and TGF-β sig-
naling, respectively. These genes include FZD3, FZD5,WNT4,
DKK1, TCF7L2 and CCND1 for WNT signaling and BMP4,
SMAD6, DCN, PITX2 and TGFB2 for TGF-β signaling (Figs. 3Ai
and Bi).
TGF-β signaling plays an important role in the fundamental
aspects of cell biology (Kitisin et al., 2007). There are multiple
mechanisms by which TGF-β signaling is negatively regulated.
SMADs are the central molecules in TGF-β signaling. Studies
have revealed that SMAD6 is induced by BMPs and SMAD1/5
(Ishida et al., 2000; Takase et al., 1998), and in the current
study an abnormal increase in the expression of SMAD6 was
observedwith RA treatment, thus substantiating the role of RA
as a negative feedback regulator of TGF-β signaling. Interest-
ingly, BMP4 and TGFB2 were found to be 3-fold and 2.4-fold
upregulated, respectively (Supplementary Table 1). To assessTable 1 Functional clustering and transcription factor pathways
day 7.
Category Term
GOTERM_BP_FAT GO:0048598~embryonic morphogenesis
GOTERM_BP_FAT GO:0035295~tube development
GOTERM_BP_FAT GO:0048568~embryonic organ develop
GOTERM_BP_FAT GO:0001501~skeletal system developm
GOTERM_BP_FAT GO:0043009~chordate embryonic deve
GOTERM_BP_FAT GO:0048562~embryonic organ morphog
GOTERM_BP_FAT GO:0030182~neuron differentiation
GOTERM_BP_FAT GO:0048706~embryonic skeletal system
GOTERM_BP_FAT GO:0060284~regulation of cell develop
GOTERM_BP_FAT GO:0048666~neuron development
GOTERM_BP_FAT GO:0035239~tube morphogenesis
GOTERM_BP_FAT GO:0001944~vasculature development
GOTERM_BP_FAT GO:0060429~epithelium development
GOTERM_BP_FAT GO:0060173~ limb development
KEGG_PATHWAY hsa04310: Wnt signaling pathway
KEGG_PATHWAY hsa04340: hedgehog signaling pathway
KEGG_PATHWAY hsa04350: TGF-beta signaling pathwaythe effect of FGF-2 on TGF-β signaling, western blotting was
performed for SMAD1/5, a critical TGF-β signaling target.
There were two conditions applied: condition I analyzed the
effects of FGF-2 treatment and condition II analyzed the
effects of RA treatment. The phosphorylation state of SMAD1/
5 was tested in hESC cultures in the presence and absence of
FGF-2. In condition I, hESCs not treated with FGF-2 showed
high levels of phosphorylation (Fig. 3A(ii) lane 1), and cultures
treatedwith FGF-2 showed no phosphorylation (Fig. 3A(ii) lane
2). In condition II, RA was added to the medium and incubated
for 1, 3 and 6 h in the presence of FGF-2. Phospho-SMAD1/5
levels increased in a time-dependent manner in hESCs treated
with RA and FGF-2 (Fig. 3A(ii) lanes 3–5). The band intensities
were quantitated using the ImageJ software, and the
phosphorylated SMAD1/5 values were normalized against the
unphosphorylated SMAD1/5 expression levels. Fold change
(FC) values under each lane indicate the normalized pSMAD1/
5 intensities. To confirm the involvement of RA and FGF-2 in
modulating the canonical WNT signaling pathway, the accu-
mulation of β-catenin in the nucleus was examined after 1, 3
and 6 h of RA treatment. As indicated in Fig. 3B(ii), β-catenin
was mainly located close to the plasma membrane in the
absence of exogenous FGF-2. Interestingly, β-catenin
translocated close to nucleus in the presence of exogenous
FGF-2. Upon treatment with RA in the presence of FGF-2,
β-catenin shuttled from the nucleus toward the plasma
membrane. This effect was time-dependent, as a complete
translocation of β-catenin from the nucleus to the plasma
membrane occurred by 6 h of RA treatment (Fig. 3B(ii)). Thus,
RA alters the expression patterns of important signaling
pathways in conjunction with FGF-2 and thereby directs
hESC differentiation.
RA induces primitive ectoderm and trophectoderm
lineage fates in hESCs
We further evaluated the effects of RA and FGF-2 on the
induction of ExE lineage markers in hESCs by identifyingexpressed in hESCs treated with RA and exogenous FGF-2 until
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Figure 3 Analysis of signaling pathways. A(i), A microarray gene profile of transcripts involved in TGF-β signaling. A(ii), Protein
expression of SMAD1/5 was analyzed by western blotting. The expression pattern of SMAD1/5 with respect to the effect of FGF-2 (condition
I) and RA (condition II). Lane 1: hESCs without RA and FGF-2 treatment; lane 2: hESCs without RA treatment in the presence of FGF-2; lanes
3, 4 and 5: hESCs, in the presence of FGF-2, treated with RA for 1, 3 and 6 h, respectively. (+ in the presence; − in the absence). The
phosphorylation fold change values have been calculated by normalizing to total SMAD1/5. B(i), A microarray gene profile of transcripts
involved in WNT signaling. B(ii), Localization of β-catenin near the plasma membrane without FGF-2, and near to the nucleus caused by
FGF-2 treatment. Upon RA treatment, β-catenin is observed near the plasma membrane. The scale bar indicates 10 μm.
234 S. Jagtap et al.over-expressed primitive endoderm and trophectoderm
markers. Markers of the primitive endoderm such as GATA6,
GATA4, AFP and DAB2, as well as trophectoderm markers,
such as GATA3, MSX1 and TFAP2α, were found to be upregu-
lated upon RA and FGF-2 treatment (Fig. 4A). As demon-
strated in Fig. 4B, similar results were obtained by qRT-PCR.
To support our findings from the gene expression data thatsuggest ExE lineage induction by RA and FGF-2, we assayed the
production of the placental hormone human chorionic
gonadotropin (hCG), which is secreted under in vivo conditions
by the placenta. As shown in Fig. 4C, RA treatment in either
the presence or absence of FGF-2 markedly increased the hCG
hormone production in a time-dependent manner, as produc-
tion was maximal after 7 days of incubation.
235All-trans retinoic acid induces extraembryonic differentiationTo further extend our understanding of RA-induced ExE
lineage differentiation and to ascertain the potential epige-
netic mechanisms involved in this process, we performed
methylation studies for the genes GATA3, EOMES, DDAH2
and TDGF1. To verify whether RA methylates CpG islands,
the percent content of CpG DNA methylation was quantified
using the Methyl-Profiler qPCR Primer Assay. The amount of
hypermethylated DNA copies increased with RA treatment
for DDAH2, TDGF1 and GATA3 with no significant hyper-
methylation (HM) of EOMES (Fig. 4D). The expression of the
ExE markers was confirmed by immunocytochemistry and
western blotting (Figs. 5A–B). The transcription factors,
GATA3 and TFAP2α, are known to be involved in the ExE
differentiation (Kuckenberg et al., 2012), and thus their
expression was examined. We observed an increase in their
expression with RA treatment in the presence of FGF-2 in
hESCs. We also studied the expression of the trophoblast
invasive gene MUC15 and trophoblast-related genes KRT7
and GATA3 by immunocytochemistry and western blotting
in independent experiments. In untreated hESCs, TFAP2α,
KRT7 and GATA3 expression was undetectable, and an
increase in its expression was observed upon RA treatment.
Overall, these results provide evidence indicating that RA
modulates FGF signaling and directs ExE differentiation in
hESCs.Discussion
The FGF-2 signaling pathway is involved in several processes,
such as self-renewal, survival, and adhesion and depending
on additional factors, induces differentiation toward certain
lineages, including trophoblast outgrowth (Eiselleova et al.,
2009; Haimovici and Anderson, 1993). The differentiation of
hESCs toward trophoblasts lineage in the absence of FGF-2
can be induced by the knockdown of genes such as SOX2 and
NANOG (for review see Schulz et al., 2008). The siRNA
silencing of POU5F1 and conditions such as the absence of
FGF-2 result in the expression of ExE markers, such as BMP4,
CGA, CGB, EOMES, ID2 and GATA2 (Hay et al., 2004; Matin
et al., 2004). NANOG is a vital gene for the maintenance of
pluripotency and is responsible for deciding lineage out-
come. The knockdown of NANOG combined with the addition
of FGF-2 has previously been reported to induce the dif-
ferentiation of hESCs into the ExE lineage (Vallier et al.,
2005; Yu et al., 2011). An analogous study reported that the
downregulation of NANOG results in an upregulation of ExE
lineage markers (Hyslop et al., 2005). TDGF1 (CRIPTO), a
co-receptor of NODAL, is expressed in explants treated with
BMP4. Thus, NODAL induction by BMP4 may induce TDGF1 in
the ExE lineage (Beck et al., 2002). Previously, it was shown
that exogenous addition of RA in trophoblast stem cells
enhances the expression of RAR family markers and aug-
ments the differentiation of these cells into trophoblast
giant cells (Yan et al., 2001).
In the current study, instead of the genetic manipulation
of pluripotent genes, we applied RA as a differentiation
inducer of hESCs in the presence of FGF-2 to induce ExE
lineage differentiation. Downregulation of pluripotency
genes such as NANOG, TDGF1, SOX2, FOXD3, LIN28, and
PODXL and upregulation of ExE markers such as CGA, MSX2,
GATA3, KRT7, and MUC15 were found upon RA treatment inthe presence of FGF-2, providing evidence for the exit of
pluripotency and the initiation of the ExE differentiation
pattern. These findings suggest that exogenous FGF-2, which
is essential for maintaining pluripotency, cannot sustain the
self-renewal potential of hESCs in the presence of RA.
Therefore, we hypothesize that RA affects the FGF-2 sig-
naling pathway and directs hESC differentiation toward the
ExE lineage.
RA plays an instrumental role in neuronal differentiation
and neuronal patterning as well as motor axon generation. In
addition, RA is required for the maintenance of mature adult
neurons (reviewed in Ferri et al., 2007). Various concentra-
tions of RA (from 1 to 10 μM) have been used to induce ESCs
into neuronal progenitor cells or to specific neuronal cell
populations that represent early or late stages of differenti-
ation (reviewed in Baharvand et al., 2007; Bel-Vialar et al.,
2002; Dhara and Stice, 2008; Pankratz et al., 2007). However,
the concentration of RA and the time of addition may
determine the commitment of cells to specific differentiation
programs. The current study reveals the differential regula-
tion of 102 neuronal differentiation-related markers as a
consequence of RA treatment (Table 1, GO:0030182~neuron
differentiation). RA and FGF-2 treatment downregulates early
neuronal markers such as NESTIN, SOX1, and PAX6 and, in
contrast, PAX6 shows an upregulation in the presence of
FGF-2. A previous study showed that early neuroectodermal
cells express PAX6 but not SOX1, and these cells were
posteriorized with RA and sonic hedgehog, which resulted in
the development of spinal motor neurons (Li et al., 2005). In
another study, it has been shown that hESC-derived neuro-
ectodermal cells express the anterior transcription factor
OTX2 but not HOXB4 without RA treatment (Hu et al., 2010).
The addition of RA after days 10 to 24 of glial differentiation
produces OTX2-negative and HOXB8-positive cells (Hu et al.,
2010). The early addition of RA in the present study caused
a negative expression of OTX2 (fore-mid brain) and LHX2
(forebrain) (Supplementary Fig. 3A) (Wigle and Eisenstat,
2008). By contrast, we observed over-expression of axon
guidance molecules such as NTRK2, SLITRK6, ROBO2 and
SEMA5A in the presence of FGF-2 (Supplementary Fig. 3B)
(Dickson, 2002). Although the expression of these molecules
commits cells to neuronal patterning, we did not find any
specific neuronal pattern markers (neither early nor late);
these markers may be sensitive to the concentration and/or
time of addition of RA. Gene markers such as BMP4, DCN,
PITX2, and TGFb2 are well-documented members of TGF-β
signaling pathways and were upregulated upon RA treatment.
We determined that genes involved in TGF-β signaling were
upregulated following RA and FGF-2 treatment. SMAD1/5 are
known to be vital for germ cell lineage commitment, and
SMAD1 is necessary in inducing the growth of the ExE lineage
(Hayashi et al., 2002; Tremblay et al., 2001). In this context,
SMAD2/3 activation is associated with the pluripotency of
hESCs, while SMAD1/5 activation is associated with differen-
tiation (James et al., 2005). SMAD4 activation and phosphor-
ylation of SMAD1/5 results in their translocation to the
nucleus, where they collectively regulate target gene expres-
sion with other transcription factors (Shi and Massague,
2003). Receptor activation by BMPs leads to the phosphory-
lation of Smad1/5, which is translocated to the nucleus after
forming a complex with Smad4. In condition I (with FGF-2),
we found that Smad1/5 was not phosphorylated when cells
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Figure 5 Cellular localization and protein quantification of trophoblast markers after RA treatment. A, Immunocytochemical
analysis for trophoblast markers after 5 days of RA treatment. (i) The presence of FGF-2, and (ii) the absence of FGF-2. The scale bar
indicates 100 μm. B, Western blot analysis of ExE markers. RA causes an increase in the protein level of trophoblast-related markers.
C, RA regulates key members of the WNT and TGF-β/BMP signaling pathways. Simplified scheme showing genes affected by RA
treatment. Red and green colors represent up and downregulation, respectively. Fold change of at least ±2.
237All-trans retinoic acid induces extraembryonic differentiationwere only treated with FGF-2, and a high phosphorylation was
observed in the absence of FGF-2. This lack of phosphoryla-
tion in the presence of FGF-2 is due to the maintenance of the
pluripotent state in hESCs. In condition II (with RA), an ele-
vation of the phosphorylation (serine/threonine) was ob-
served at 6 h of RA and FGF-2 treatment. This result suggests
that RA modulates TGF-β signaling in the presence of FGF-2.
A number of transcripts involved in WNT signaling, such as
WNT4, FZD, WIF1 and DKK1, were downregulated upon RA
treatment.WNT activation plays a crucial role in directing cell
fates during embryogenesis, and this signaling also maintains
pluripotency via FGF-2 stimulation and phosphorylation of
GSK3β followed by nuclear translocation of β-catenin.Figure 4 Expression of extraembryonic lineage markers. A, A micro
primitive endoderm markers (lower panel). B,(i) Real-time PCR a
markers (*P-value≤0.01; −FGF-2, +RA vs. −FGF-2, −RA and +FGF-2,
human chorionic gonadotropin (hCG). Culture media from hESCs gro
collected at the indicated times and used for immunoassays for
+FGF-RA). D, RA induces the methylation of the trophoblast-relate
analysis of cytosine methylation percentage is represented on the y-a
methylated—IM percentages are depicted as histograms. The bar shoImmunocytochemistry analysis showed that β-catenin local-
izes to the nucleus in the presence of FGF-2 and thereby
activates WNT target genes to maintain pluripotency. By
contrast, RA treatment coupled with the absence of FGF-2
causes β-catenin to relocate to the plasma membrane, which
demonstrates that RA overrides the effect of FGF-2 by
potentially inhibiting WNT signaling and directing cells toward
ExE differentiation.
To define the transcriptome of the ExE lineage in the present
study, we analyzed primitive endoderm and trophectoderm
markers using qRT-PCR. Interestingly, we found that markers of
the primitive endoderm, such as DDAH2, LAMB1, DAB2, AFP and
NR2F1 (COUP-TF1), and markers of the trophectoderm, such asarray gene profile for trophectoderm markers (upper panel) and
nalysis of trophectoderm markers and (ii) primitive endoderm
+RA vs. +FGF-2, −RA). C, Immunoassays for placental hormone
wn in the presence or absence of RA and exogenous FGF-2 were
hCG (*Pb0.05 for +FGF-2+RA or −FGF-2+RA vs. −FGF-RA or
d markers DDAH2, TDGF1, GATA3 and EOMES. The quantitative
xis. Hypermethylated—HM, unmethylated—UM and intermediate
ws the mean value from three technical replicates.
238 S. Jagtap et al.GATA3, MSX1 and KRT7, were upregulated upon RA treatment.
The result of our study corroborates previous investigation
reporting that over-expression of NR2F1 in murine embryonic
stem cells leads to RA-induced ExE endoderm gene expression
(Zhuang and Gudas, 2008). The DAB2 and GATA factors play a
major role in the primitive endoderm during early embryogen-
esis. Through studies with knockout mice, it was established
that GATA4 and GATA6 are required for ExE lineage formation
(Fujikura et al., 2002). DAB2 is expressed in the ExE visceral
endoderm during early mouse development and is required for
growth of the inner cell mass (Morris et al., 2002; Yang et al.,
2002). A selective expression of GATA3 is observed in the
trophectoderm and is also responsible for trophoblast develop-
ment (Home et al., 2009; Ralston et al., 2010b). To further
characterize the ExE lineage, we analyzed the amount of
placental hormone hCG produced by hESCs treated with RA in
the presence or absence of exogenous FGF-2. An elevation of
hCG production was observed in a time dependent manner
during ExE differentiation.
The ExE lineage develops into multiple placental cell
types. Trophoblast cell lineage differentiation and develop-
ment is restricted to ExE tissues. In this context, epigenetic
modifications are involved in normal trophoblast differenti-
ation and ExE tissue functions (Hemberger, 2010). The
transcription factor GATA3 is capable of the induction of
trophoblast differentiation in parallel to CDX2 (Ralston et
al., 2010). In addition, the expression of the DDAH2 and
EOMES genes is required for the establishment of tropho-
blast lineage (Ayling et al., 2006; Russ et al., 2000; Tanaka
et al., 1998). The hypermethylation of DDAH2 has been
previously reported in trophoblast stem cells (Tomikawa et
al., 2006) and is highly consistent with our observed
hypermothylation of TDGF1 and GATA3 and, to a lesser
extent, EOMES. The microarray expression patterns of these
genes correspond to the methylation status, with no
expression of DDAH2, 42.8-fold downregulation of TDGF1,
7.5-fold upregulation of GATA3 and 1.2-fold downregulation
of EOMES. The growth factor TDGF1 is required for the
anterior–posterior axis positioning and is restricted to the
ExE region (Ding et al., 1998; Rodriguez et al., 2005). The
expression of KRT7, GATA3 and TFAP2α was assessed with
immunocytochemistry and western blotting. ExE markers
appear to be expressed prominently during RA treatment,
and the presence of FGF-2 did not affect their expression.
In conclusion, our study shows that treatment with RA in
the presence of FGF-2 induces the phosphorylation of
SMAD1/5 and facilitates the translocation of β-catenin to
the nucleus, thus further affecting the downstream targets
of the WNT, BMP and TGF-β signaling pathways. TGF-β
signaling is associated with trophectoderm differentiation,
and stimulation of BMP4 leads to the activation of GATA4
and GATA6 and consequently to GATA3 mediated tropho-
blast differentiation (Fig. 5C). We propose that RA in-
fluences cell fate changes by modulating the WNT, BMP and
TGF-β signaling pathways during embryogenesis and directs
ExE differentiation in hESCs. The findings from this study
reveal the dynamics of gene regulation through RA-driven
ExE lineage formation.
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